Issue 3 : May/June 2003
Supplements and Sustenance Regulating Dietary Supplements & Infant Formula
May/June 2003
Subscription Information
FDLI members receive Update as part of membership.
Additional
copies or back issues are available at $15 each.
GMPs for Dietary Supplements: Raising the Bar
by Scott Bass, Partner in the law firm of Sidley Austin Brown &
Wood, in Washington, D.C., where he heads the firm's international food
and drug law practice. He is the author of two FDLI books on DSHEA
Dietary Supplement Labeling and FDA Regulatory Enforcement
by Stephen H. McNamara, Partner in the law firm of Hyman, Phelps &
McNamara, P.C., Washington, D.C.
"Health Delivery" v. "Health Halo" Positions
Using Qualified Health Claims: Unconventional Ingredients in Conventional
Foods
by Nancy Childs, Ph.D., Professor of Food Marketing in the Erivan K.
Haub School of Business at Saint Joseph's University (SJU), Philadelphia,
PA, and a Founding Director of the Nutraceutical Institute, a partnership
with SJU and Rutgers University. This article summarizes the author's
presentation delivered at FDLI's Conference "Dietary Supplements
at a Crossroads," Washington, D.C. (Jan 17, 2003)
Dietary Supplement Research Initiatives at NIH
by Director of the Office of Dietary Supplements, National Institutes
of Health,
Department of Health and Human Services, Bethesda, MD
Crossing the Tricky Terrain of Dietary Supplement Regulation
by Lauren Swann, M.S., R.D.President of Concept Nutrition, Inc., a consultancy
specializing in food labeling regulations, marketing and technical communications,
and ethnic dietary practices, Bensalem, PA
At the Crossroads: The Dietary Supplement Health and Education
Act
by Thomas N. Tiedt, Ph.D., Director of Med-Tox Group, a healthcare R&D
consulting company, Longboat Key, FL
FDA's Poison Prevention Packaging Rule: A Bitter Pill That the
Agency Must Swallow
by John M. Desiderio, Of Counsel to the law firm of Jacobs deBrauwere
LLP, New York, NY. He represented the plaintiff and argued the appeal
in the case that is the subject of this article
Consumer Justice Center v. Olympian Labs: A Presumption Against
Preemption
by Matthew G. Ball, Associate with the law firm of Kirkpatrick &
Lockhart, San Francisco, CA
Infant Formula Regulation Today
by Fred H. Degnan, Partner in the law firm of King & Spalding, Washington,
D.C.
Project BioShield: A New Opportunity for Prescription Product
Manufacturers
by James M. Wood, Partner in the law firm of Reed Smith Crosby Heafey,
Oakland, CA
New Canadian Food Labeling Regulations
by Gordon S. Jepson, Partner at the law firm of Deeth Williams Wall
LLP, Toronto, Canada, where he practices intellectual property and regulatory
law
and M. Susana Diaz, Associate at the law firm of Deeth Williams Wall
LLP, Toronto, Canada
Hormone Replacement Therapy: Clinical Trials and Controversy
by Raphael J. Witorsch, Ph.D., Professor of Physiology at the School
of Medicine, Medical College of Virginia, Virginia Commonwealth University,
Richmond, VA
Making History
For the Bookshelf-Hilts on History: Protecting America's Health
by Suzanne White Junod, Ph.D., Historian with the Food and Drug Administration,
Rockville, MD
Enforcement Corner
Enhanced Protection for Whistleblowers
by Steven M. Kowal, Partner in the law firm of Bell, Boyd & Lloyd,
Chicago, IL
Global Corner
Changing Views on Health and Nutrition Labeling in Europe
by Matthew Weinberg, Chief Executive Officer of THE WEINBERG GROUP,
Washington, D.C.
Associate's Corner
FDA Proposes Food Facility Registration and Prior Notice of Food
Imports
by Christopher A. Brown, Associate in the food and drug practice group
at the law firm of Sonnenschein Nath & Rosenthal, Washington, D.C.
Note: All author affiliations are current as of the date of publication of the issue.
(Note: All author affiliations are current as of the date of publication of the issue.)
